HER2 Support Group Forums - View Single Post - Coming conference on antiangiogenesis (Oct 16-17)

heblaj01 · 08-30-2006, 08:59 AM

For those who may want to attend the 2 day conference in Boston:
http://www.ibclifesciences.com/antiangio
October 16-17, 2006 - Sheraton Boston Hotel - Boston, MA

Part of the agenda is including:
Explore new targets for antiangiogenic therapy and receive clinical updates of agents now in development

Amgen, GlaxoSmithKline, Pfizer and Bayer share their latest clinical results and updates

Genentech describes their research on neuropilin-1, a new potential angiogenesis target

ARIAD Pharmaceuticals offers an in-depth look at mTOR inhibition for dual targeting of tumor prolifieration and angiogenesis

Dana Farber Cancer Center provides new data showing metronomic chemotherapy as anti-angiogenic treatment

08-30-2006, 08:59 AM	#1
heblaj01 Senior Member Join Date: Apr 2006 Posts: 543	Coming conference on antiangiogenesis (Oct 16-17) For those who may want to attend the 2 day conference in Boston: http://www.ibclifesciences.com/antiangio October 16-17, 2006 - Sheraton Boston Hotel - Boston, MA Part of the agenda is including: Explore new targets for antiangiogenic therapy and receive clinical updates of agents now in development Amgen, GlaxoSmithKline, Pfizer and Bayer share their latest clinical results and updates Genentech describes their research on neuropilin-1, a new potential angiogenesis target ARIAD Pharmaceuticals offers an in-depth look at mTOR inhibition for dual targeting of tumor prolifieration and angiogenesis Dana Farber Cancer Center provides new data showing metronomic chemotherapy as anti-angiogenic treatment